Investing Profile
David Mott
InvestorVC
Private Investor at Mott Family Capital
Montana
Your Intro Paths to David Mott
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks David is a member of
New Enterprise Associates (NEA) Network
33 CONNECTIONS
Find David Mott on
cbCurrent Investing Position
Mott Family Capital Investor
Investment Range
$100K - $10.0M
Sweet Spot
$1M
Investments On Record
14
David Mott is on these Sector & Stage Rankings
David Mott's Investments On Record (10)
Company | StageDateRound Size | Total Raised |
---|---|---|
Sagimet Biosciences | Series EAug 2019$7M | $190M |
Nightstar Therapeutics | Series CJun 2017$45M Series BNov 2015$35M | $80M |
Ardelyx | Post-IPO EquityJul 2016$110M Post-IPO EquityJun 2015$78M Series BAug 2011$30M | $220M |
Clementia Pharmaceuticals | Venture RoundJun 2015$60M | $93M |
Adaptimmune | Series ASep 2014$100M | $100M |
Cydan | Venture RoundOct 2013$10M Venture RoundApr 2013$16M | $26M |
Edimer Pharmaceuticals | Series BJul 2013$18M | $18M |
Prosensa | Venture RoundJan 2012€23M | €23M |
David Mott's Experience
General Partner New Enterprise Associates (NEA)2008 - 2020
Investors who invest with David Mott
Founders who looked at David Mott's profile also looked at these Scouts & Angels